Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...

The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...

Drugmakers will offer Eliquis at a 43% discount to uninsured U.S. patients, bypassing insurers and PBMs New $346 monthly ...

Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient models from Eli Lilly and Novo Nordisk.

Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...

Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.

The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

The companies' new effort would bypass traditional middlemen to cut the drug's monthly cost from a list price of around $606 to $346.

Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially ...

Many studies have shown that even though these medicines have risks, these risks are much lower than the risk of a stroke ...